Insider · CIK 0001384243
Barry D Quart
director
Files at KNSA (Kiniksa Pharmaceuticals International, plc). First filing Jun 11, 2025, latest Feb 12, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $2.5M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KNSA: Kiniksa Pharmaceuticals International, plc
KNSAOct 9, 2026 · close 79.78
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 4Weak | Kiniksa Pharmaceuticals International, plc | $126k 2,800 shares | -22% | +140% from low-1% from high | |
| 29Weak | Kiniksa Pharmaceuticals International, plc | $722k 15,960 shares | -119% | +140% from low0% from high | |
| 38Weak | Kiniksa Pharmaceuticals International, plc | $836k 20,129 shares | -62% | +129% from low-3% from high | |
| 58Moderate | Kiniksa Pharmaceuticals International, plc | $833k 27,448 shares | -141% | +67% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +110 | $15.47 | $1,702 | 12,656 | Feb 12, 2026 |
| Feb 10, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -110 | $45.00 | $4,950 | 12,546 | Feb 12, 2026 |
| Feb 12, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +2,690 | $15.47 | $42k | 15,236 | Feb 12, 2026 |
| Feb 12, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -2,690 | $45.00 | $121k | 12,546 | Feb 12, 2026 |
| Feb 10, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -110 | $0.00 | $0 | 2,690 | Feb 12, 2026 |
| Feb 12, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -2,690 | $0.00 | $0 | 0 | Feb 12, 2026 |
| Feb 2, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +830 | $15.47 | $13k | 13,376 | Feb 4, 2026 |
| Feb 2, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -830 | $45.00 | $37k | 12,546 | Feb 4, 2026 |
| Feb 3, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +12,528 | $15.47 | $194k | 25,074 | Feb 4, 2026 |
| Feb 3, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -12,528 | $45.27 | $567k | 12,546 | Feb 4, 2026 |
| Feb 4, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +2,602 | $15.47 | $40k | 15,148 | Feb 4, 2026 |
| Feb 4, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -2,602 | $45.02 | $117k | 12,546 | Feb 4, 2026 |
| Feb 2, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -830 | $0.00 | $0 | 17,930 | Feb 4, 2026 |
| Feb 3, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -12,528 | $0.00 | $0 | 5,402 | Feb 4, 2026 |
| Feb 4, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -2,602 | $0.00 | $0 | 2,800 | Feb 4, 2026 |
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share10b5-1 | +20,129 | $10.36 | $209k | 32,675 | Dec 17, 2025 |
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share10b5-1 | -20,129 | $41.51 | $836k | 12,546 | Dec 17, 2025 |
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative10b5-1 | -20,129 | $0.00 | $0 | 0 | Dec 17, 2025 |
| Jun 9, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +6,900 | $3.80 | $26k | 19,446 | Jun 11, 2025 |
| Jun 9, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share | -6,900 | $30.26 | $209k | 12,546 | Jun 11, 2025 |
| Jun 10, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +8,212 | $3.80 | $31k | 20,758 | Jun 11, 2025 |
| Jun 10, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share | -8,212 | $30.36 | $249k | 12,546 | Jun 11, 2025 |
| Jun 11, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +12,336 | $3.80 | $47k | 24,882 | Jun 11, 2025 |
| Jun 11, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | SOpen-market sale Class A Ordinary Share | -12,336 | $30.39 | $375k | 12,546 | Jun 11, 2025 |
| Jun 9, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative | -6,900 | $0.00 | $0 | 20,548 | Jun 11, 2025 |
| Jun 10, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative | -8,212 | $0.00 | $0 | 12,336 | Jun 11, 2025 |
| Jun 11, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Share Optionderivative | -12,336 | $0.00 | $0 | 0 | Jun 11, 2025 |
| Jun 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Class A Ordinary Share | +3,173 | - | - | 12,546 | Jun 5, 2025 |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Share Optionderivative | +16,798 | $0.00 | $0 | 16,798 | Jun 5, 2025 |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | AGrant or award Restricted Share Unitsderivative | +2,799 | $0.00 | $0 | 2,799 | Jun 5, 2025 |
| Jun 5, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | MOption exercise Restricted Share Unitsderivative | -3,173 | $0.00 | $0 | 0 | Jun 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.